Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
Clinical Infectious Diseases2009Vol. 50(2), pp. 184–191
Citations Over TimeTop 1% of 2009 papers
Amanda Cohn, Jessica R. MacNeil, Lee H. Harrison, Cynthia Hatcher, Jordan M. Theodore, Mark A. Schmidt, Tracy Pondo, Kathryn E. Arnold, Jan Baumbach, Nancy M. Bennett, Allen S. Craig, Monica M. Farley, Ken Gershman, Susan Petit, Ruth Lynfield, Arthur Reingold, William Schaffner, Kathleen A. Shutt, Elizabeth R. Zell, Leonard W. Mayer, Thomas A. Clark, David S. Stephens, Nancy E. Messonnier
Abstract
Before the introduction of the quadrivalent meningococcal conjugate vaccine, the incidence of meningococcal disease in the United States decreased to a historic low. However, meningococcal disease still causes a substantial burden of disease among all age groups. Future vaccination strategies may include targeting infants and preventing serogroup B meningococcal disease.
Related Papers
- → Enter B and W: two new meningococcal vaccine programmes launched(2015)107 cited
- → Neisseria meningitidisB vaccines(2011)46 cited
- → National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease(2023)7 cited
- → Genome-based study of a spatio-temporal cluster of invasive meningococcal disease due to Neisseria meningitidis serogroup C, clonal complex 11(2016)22 cited
- → Meningococcal Vaccines(2007)9 cited